0000899243-21-031954.txt : 20210806
0000899243-21-031954.hdr.sgml : 20210806
20210806180827
ACCESSION NUMBER: 0000899243-21-031954
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210804
FILED AS OF DATE: 20210806
DATE AS OF CHANGE: 20210806
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHELLER RICHARD H
CENTRAL INDEX KEY: 0001214133
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38959
FILM NUMBER: 211154087
MAIL ADDRESS:
STREET 1: C/O GENENTECH INC
STREET 2: 1 DNA WAY MS 49
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080-4990
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BridgeBio Pharma, Inc.
CENTRAL INDEX KEY: 0001743881
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: (650) 391-9740
MAIL ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
FORMER COMPANY:
FORMER CONFORMED NAME: BridgeBio Pharma LLC
DATE OF NAME CHANGE: 20180618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-04
0
0001743881
BridgeBio Pharma, Inc.
BBIO
0001214133
SCHELLER RICHARD H
C/O BRIDGEBIO PHARMA, INC.
421 KIPLING STREET
PALO ALTO
CA
94301
1
1
0
0
See Remarks
Common Stock
2021-08-04
4
M
0
13777
17.00
A
59637
D
Common Stock
2021-08-04
4
S
0
13777
53.2276
D
45860
D
Stock Option (Right to Buy)
17.00
2021-08-04
4
M
0
13777
0.00
D
2029-06-26
Common Stock
13777
39611
D
Represents the weighted average sale price of the shares sold from $52.839 to $53.68 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in this footnote.
The shares subject to this option vest and become exercisable in 48 equal monthly installments after June 26, 2019, subject to the Reporting Person's continued service to the Issuer through each such date.
Title: Chairman of Research and Development
/s/ Yi Ching Yau, Attorney-in-Fact
2021-08-06